Jelena V. Jovanovic

37 North Wharf Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Low-Dose Atropine and Other Interventions for Pediatric Myopia: A Systematic Review and Bayesian Network Meta-analysis of Efficacy and Post-treatment Outcomes.

Low-Dose Atropine and Other Interventions for Pediatric Myopia: A Systematic Review and Bayesian Network Meta-analysis of Efficacy and Post-treatment Outcomes.

Journal: Ophthalmology and therapy
Published: May 29, 2026

Blinatumomab for measurable residual disease relapse in acute myeloid leukemia with t(8;21) translocation: the BlinAML Trial.

Blinatumomab for measurable residual disease relapse in acute myeloid leukemia with t(8;21) translocation: the BlinAML Trial.

Journal: Haematologica
Published: April 21, 2026

Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Journal: Blood advances
Published: May 23, 2025

Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML.

Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML.

Journal: Blood
Published: April 18, 2025

Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia.

Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia.

Journal: Blood
Published: August 19, 2024

Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials.

Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials.

Journal: The Lancet. Haematology
Published: May 01, 2024

Pitfalls in Diagnosis: JMML versus KMT2A Rearranged Juvenile AML.

Pitfalls in Diagnosis: JMML versus KMT2A Rearranged Juvenile AML.

Journal: Case reports in hematology
Published: April 05, 2024

Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML.

Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML.

Journal: Blood
Published: February 27, 2024

Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.

Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.

Journal: Blood
Published: November 03, 2023

Bacillus cereus Sensu Lato Accelerate Cellular Bioenergetic Metabolism of Human Colorectal Adenocarcinoma Caco-2 Cell Line.

Bacillus cereus Sensu Lato Accelerate Cellular Bioenergetic Metabolism of Human Colorectal Adenocarcinoma Caco-2 Cell Line.

Journal: Foodborne pathogens and disease
Published: October 13, 2023

Granulocyte transfusion during cord blood transplant for relapsed, refractory AML is associated with massive CD8+ T-cell expansion, significant cytokine release syndrome and induction of disease remission.

Granulocyte transfusion during cord blood transplant for relapsed, refractory AML is associated with massive CD8+ T-cell expansion, significant cytokine release syndrome and induction of disease remission.

Journal: British journal of haematology
Published: February 16, 2023

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.

Journal: Blood advances
Published: October 28, 2022
Showing 1-12 of 34

Last Updated: 09/26/2026